Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON)

Wim A. Wuyts, Luca Richeldi, Shervin Assassi, Arata Azuma, Vincent Cottin, Anna-Maria Hoffmann-Vold, Michael Kreuter, Justin M. Oldham, Fernando J. Martinez, Claudia Valenzuela, Marlies S. Wijsenbeek, Madhu Kanakapura, Alexandra James, Gerrit Weimann, Cyril Drzewuski, Carl Coeck, Toby M. Maher

Open source

DOI: 10.1186/s12890-025-03973-7
Published: 2025-12-04
Container: BMC Pulmonary Medicine
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12890-025-03973-7,
  title = {Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON)},
  author = {Wim A. Wuyts and Luca Richeldi and Shervin Assassi and Arata Azuma and Vincent Cottin and Anna-Maria Hoffmann-Vold and Michael Kreuter and Justin M. Oldham and Fernando J. Martinez and Claudia Valenzuela and Marlies S. Wijsenbeek and Madhu Kanakapura and Alexandra James and Gerrit Weimann and Cyril Drzewuski and Carl Coeck and Toby M. Maher},
  year = {2025},
  journal = {BMC Pulmonary Medicine},
  doi = {10.1186/s12890-025-03973-7},
  url = {https://doi.org/10.1186/s12890-025-03973-7}
}

RIS

TY  - JOUR
TI  - Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON)
AU  - Wim A. Wuyts
AU  - Luca Richeldi
AU  - Shervin Assassi
AU  - Arata Azuma
AU  - Vincent Cottin
AU  - Anna-Maria Hoffmann-Vold
AU  - Michael Kreuter
AU  - Justin M. Oldham
AU  - Fernando J. Martinez
AU  - Claudia Valenzuela
AU  - Marlies S. Wijsenbeek
AU  - Madhu Kanakapura
AU  - Alexandra James
AU  - Gerrit Weimann
AU  - Cyril Drzewuski
AU  - Carl Coeck
AU  - Toby M. Maher
PY  - 2025
JO  - BMC Pulmonary Medicine
DO  - 10.1186/s12890-025-03973-7
UR  - https://doi.org/10.1186/s12890-025-03973-7
ER  -

APA

Wuyts, W. A., Richeldi, L., Assassi, S., Azuma, A., Cottin, V., Hoffmann-Vold, A., Kreuter, M., Oldham, J. M., Martinez, F. J., Valenzuela, C., Wijsenbeek, M. S., Kanakapura, M., James, A., Weimann, G., Drzewuski, C., Coeck, C., & Maher, T. M. (2025). Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON). BMC Pulmonary Medicine. https://doi.org/10.1186/s12890-025-03973-7

Source records

crossref · retrieved 2026-09-26T19:18:12.891Z